Events
6 - 10 Oct 2024
The 5th HIV Research for Prevention Conference
HIVR4P 2024, the 5th HIV Research for Prevention Conference will take place in Lima, Peru, and virtually from 6 to 10 October 2024 and is expected to bring together around 1,500 participants.
View details View details
22 - 26 Jul 2024
The 25th International AIDS Conference
AIDS 2024, the 25th International AIDS Conference, will take place in Munich, Germany, and virtually from 22 to 26 July 2024 and is expected to bring together some 18,000 participants from around the world.
View details View details
23 Jul 2023 - 27 Jul 2023
The 12th IAS Conference on HIV Science
IAS 2023, the 12th IAS Conference on HIV Science, will take place in Brisbane, Australia, and virtually from 23 to 26 July 2023. IAS 2023, being held at the Brisbane Convention and Exhibition Centre, will shine a spotlight on the world’s advances in HIV research.
View details View details
22 Jul 2023
2023 HIV Cure & Immunotherapy Forum
The 2023 HIV Cure & Immunotherapy Forum, organized by the IAS Towards an HIV Cure initiative, will be held at the Brisbane Convention & Exhibition Centre in Brisbane, Australia, on 22 July 2023 alongside IAS 2023, the 12th IAS Conference on HIV Science. The content of the Forum will be accessible online after the meeting. Following the success of the 2019 HIV & HBV Forum and the 2021 HIV Cure and Gene Therapy Forum, the 2023 Forum will focus on the intersection between immunotherapy and HIV cure research, building on recent advances in both fields. Its main goals are to establish a unified definition for post-intervention control, understand the biological impact of immunotherapies for cure, understand the underlying mechanisms, and learn from advances in immunotherapies in cancer therapeutics and vaccine development. The Forum will include invited speakers, an oral abstract discussion and a panel discussion incorporating perspectives from both fields and highlighting current research directions. Forum objectives Accelerate research on immunotherapy curative strategies. Create an environment to foster interdisciplinary collaborations and merge the HIV cure and immunotherapy disciplines. Provide an opportunity for the next generation of investigators to launch their careers through interaction and discussion with peers. Promote engagement of researchers, advocates, social and behavioural scientists, ethicists, philanthropic organizations and the private sector and seek to promote research in low- and middle-income settings. Promote increased investments in cure research. Provide a platform for information sharing, debate and networking among peers. Programme Committee Thumbi Ndung'u, Beatriz Mothe Pujadas and Anthony Kelleher will co-chair the meeting. The Forum Programme Committee will be made up of experts from both fields and include Sharon Lewin and Steve Deeks, the inaugural Co-Chairs of the IAS Towards an HIV Cure forums. Please see the scientific programme here. Sign-up To encourage the broadest participation in the forum, sign-up will be free. However, the meeting will be in person only and limited to 300 attendees. Please note you may only sign up for one IAS 2023 pre-meeting. Sign up Please note that signing up for the pre-meeting does not grant you access to IAS 2023; a separate registration is required for the main event.
View details View details
22 Jul 2023
Putting people first in the prevention, treatment and care of HPV-related cancers among people living with HIV
IAS – the International AIDS Society – and its partners are organizing a one-day pre-meeting, titled “Putting people first in the prevention, treatment and care of HPV-related cancers for people living with HIV”, in conjunction with IAS 2023, the 12th IAS Conference on HIV Science. The event will be held at the Pullman & Mercure King George Square Hotel, Corner of Ann & Roma Street, Brisbane, 4000, Australia, on 22 July 2023. The content will be accessible online after the pre-meeting. This pre-meeting will be of interest to HIV basic scientists, clinicians, researchers, public health practitioners, implementers, community advocates and those working towards preventing and managing HPV-related cancers. People with HIV experience a substantially increased incidence of cancers associated with human papillomavirus (HPV), including cervical cancer, anal cancer, other anogenital cancers and oro-pharyngeal cancer. Globally, cervical cancer is the most common cancer in women living with HIV, and people living with HIV are more likely to develop cervical cancer at a younger age. Scale up of HPV vaccination, screening and treatment are required to meet the ambitious targets of the World Health Organization to eliminate cervical cancer as a public health problem by 2030. People living with HIV should be prioritized in this scale up. Anal cancer is a common cancer in people living with HIV and is among the most common of all cancers in men having sex with men living with HIV. Like cervical cancer, future anal cancer cases will eventually be prevented by HPV vaccination of children. In addition, screening in people living with HIV, analogous to the cervical model, has been proposed. In 2022, a large, randomized trial reported for the first time that treatment of screen-detected pre-cancer reduced the incidence of anal cancer. Clinical societies will need to adjust to these new results and the reality that screening and treatment to prevent anal cancer is needed in people living with HIV. The objective of the meeting is to bring together a diverse group of scientific, technical and community representatives to discuss current opportunities and challenges for increased prevention and screening for HPV, as well as diagnosis and treatment of intraepithelial neoplasia to prevent cervical cancer and anal cancer in people living with HIV and other populations. Programme and Organizing Committee Adeeba Kamarulzaman, Monash University, Malaysia Andrew Grulich, Kirby Institute, University of NSW, Australia Joel Palefsky, University of California San Francisco, United States Sinead Delany-Moretlwe, University of the Witwatersrand, South Africa Programme overview 09:00 – 10:00 Session 1 – Welcome and introduction: The scale of the challenges 10:00 – 10:30 Break 10:30 – 12:00 Session 2 – State-of-the-art guidance for vaccination, screen and treat 12:00 – 13:00 Lunch provided on site 13:00 – 14:30 Session 3 – Good-practice models for HPV cancer elimination 14:30 – 15:00 Break 15:00 – 15:45 Session 4 – Discussion: Current and future research gaps related to HPV cancer elimination 15:45 – 16:00 Break 16:00– 17:00 Session 5 – Discussion: Call to action 17:00 – 18:00 Networking reception See programme details and featured speakers here. Sign-up To encourage the broadest participation in the forum, sign-up will be free. However, the meeting will be in person only and limited to 250 attendees. Please note you may only sign up for one IAS 2023 pre-meeting. Sign up Please note that signing up for the pre-meeting does not grant you access to IAS 2023; a separate registration is required for the main event. Proudly supported by major donor and organizing partner: With support from bronze sponsor: With support from: table.table-fix { table-layout: fixed; margin-top: 32px; margin-bottom: 48px; } table.table-fix tr td { padding: 12px 16px; border-right: 2px solid #fff; } table.table-fix tr:nth-child(2n) td { background-color: #f2f5f6; }
View details View details
22 Jun 2023
Science and community in the HIV response in the Democratic Republic of Congo
Séminaire scientifique post-conférence AIDS 2022 organisé en partenariat avec la Fondation Femme Plus (gratuit) IAS – the International AIDS Society – organise un séminaire scientifique de l’IAS Educational Fund en partenariat avec la Fondation Femme Plus sur le thème « Science et communautés dans la réponse au VIH en République Démocratique du Congo ». Ce séminaire se tiendra le 22 juin 2023 à Kinshasa, en République Démocratique du Congo (RDC). Ce séminaire fait suite à la 24ème Conférence Internationale sur le SIDA (AIDS 2022). Les intervenants et les participants discuteront des sujets clés suivants: Statut de la réponse au VIH en RDC et dans la région Messages clés de la Conférence AIDS 2022 Prise en charge pédiatrique et élimination de la transmission verticale: Dernières avancées scientifiques Stratégies innovantes en matière de prévention combinée Stigmatisation et discrimination dans la réponse au VIH Ce séminaire gratuit est ouvert aux cliniciens, prestataires de services de santé et de services sociaux, chercheurs, responsables politiques, activistes, membres des populations clés et vulnérables et représentants des personnes vivants avec le VIH. Ce séminaire se déroulera en français. Inscrivez-vous maintenant Science and community in the HIV response in the Democratic Republic of Congo The Educational Fund of IAS – the International AIDS Society – is organizing a scientific symposium in partnership with Fondation Femme Plus, titled “Science and community in the HIV response in the Democratic Republic of Congo”. The symposium is a follow up to AIDS 2022, the 24th International AIDS Conference, and will be held in Kinshasa, Democratic Republic of the Congo, on 22 June 2023. Speakers and participants will discuss the following key themes: The status of the HIV response in the DRC and the region Key messages from AIDS 2022 Latest scientific advances in paediatric care and elimination of vertical transmission Innovative combination prevention strategies An HIV response without stigma and discrimination This free symposium is open to clinicians, health and social service providers, researchers, political decision makers, activists, key and vulnerable population representatives, and people living with HIV. This symposium will be held in French.
View details View details
7 Feb 2023
Webinar: Growing older with HIV in the Treat-All Era
This webinar will feature Guest Editors and authors of the recent JIAS special issue, “Growing older with HIV in the Treat-All Era”.
View details View details
27 Oct 2022
Todos unidos en la respuesta al VIH: Ciencia, gobierno y sociedad civil
IAS – the International AIDS Society – in partnership with the Sociedad Chilena de Infectología (SOCHINF), is pleased to invite you to a scientific symposium, titled “Todos unidos en la respuesta al VIH: Ciencia, gobierno y sociedad civil”, which will be held in person in Santiago, Chile, on 27 October 2022. Presentations will cover the following topics: PrEP and prevention HIV treatment Diagnostics and self-tests HIV vaccines HIV cure This event will take place in Spanish. View the full programme
View details View details
11 Oct 2022 - 13 Oct 2022
Fast-Track Cities 2022 conference
Accelerating urban HIV, tuberculosis and viral hepatitis responses
View details View details
20 Sep 2022
Building regulatory and ethics expertise for experimental medicine
This webinar will explore ways to improve the knowledge and capabilities of regulatory authorities to assess experimental medicine clinical research in high-income and low- and middle-income countries.
View details View details
6 Sep 2022
Engaging adolescent girls and young women in HIV prevention research – Unpacking the ethical dilemmas
The second in a two-part series, it will explore how we can leverage learnings from behavioural research to enhance better engagement of adolescent girls and young women in HIV programmes and research.
View details View details
30 Aug 2022
Engaging adolescent girls and young women in HIV prevention research – Unpacking the ethical dilemmas
The first in a two-part series, it will explore the need for engaging adolescent girls and young women in HIV research and help understand latest scientific developments and the ethical dilemmas.
View details View details
29 Jul 2022 - 3 Aug 2022
The 24th International AIDS Conference
For the first time, the world’s largest conference on HIV and AIDS will be hosted in person in Montreal, Canada, as well as virtually, to make it accessible to as many people as possible.
View details View details
28 Jul 2022
Pathways to an HIV cure: Research and advocacy priorities
IAS – the International AIDS Society – through its Towards an HIV Cure programme, organised the annual HIV cure meeting just before AIDS 2022, the 24th International AIDS Conference, as an Affiliated Independent Event. The hybrid meeting was organised in partnership with the Canadian HIV Cure Enterprise (CanCURE) and the FRQS - AIDS and Infectious Diseases Research Network. It took place in person at the Centre Hospitalier de l'Université de Montréal (CHUM) and virtually on 28 July 2022. The meeting programme was designed to reflect the “Research priorities for an HIV cure: IAS Global Scientific Strategy 2021”, published in Nature Medicine. The sessions highlighted cure advances globally and promising research strategies while translating the latest science and incorporating diverse perspectives on HIV cure. You can access all the meeting materials using the links below: Programme Recordings Presentations: Pathways to an HIV cure: Research and advocacy priorities - Welcome! IAS Global Scientific Strategy 2021 - Sharon Lewin, IAS & The Peter Doherty Institute for Infection and Immunity, Australia The science in context: a community perspective - Simon Collins, i-Base, UK Berlin, London, Dusseldorf and New York Patients - Kumitaa Theva Das, Universiti Sains Malaysia, Malaysia HIV Cure in the News: The South African child - Maria Paximadis, University of the Witwatersrand and National Institute for Communicable Diseases (Cell Biology), South Africa The San Francisco and Esperanza patients - Gabriela Turk, University of Buenos Aires, Argentina Exceptional HIV Elite Controllers - Javier Martinez-Picado, irsiCaixa AIDS Research Institute, Spain The Philadelphia patient - Pablo Tebas, University of Pennsylvania, USA amfAR-UCSF HIV Cure Trial - Michael Peluso, University of California, San Francisco, USA Considerations for cis-Women in HIV Cure Research - Jessica Prodger, Western University, Canada End of life research - Caroline Dufour, Université de Montréal, Canada The Last Gift Update - Jeff Taylor, University of California AntiViral Research Center, USA Virology of the reservoir - Zabrina Brumme, Simon Fraser University, Canada Broadly neutralizing antibodies and the HIV reservoir - Christian Gaebler, The Rockefeller University, USA Landscape analysis & diversifying efforts - Elizabeth Barr, National Institutes of Health, USA SHIV Reservoirs Persist Following CAR T Cell-Mediated Depletion of B Cell Follicles in Nonhuman Primates - Chris Peterson, Fred Hutch Cancer Center, USA Block, Lock, & Excise - Lishomwa Ndhlovu, Weill Cornell Medicine, USA HIV reactivation from latency using a Tat compound - Marion Pardons, Ghent University, Belgium The FRESH Cohort: 10 years of Acute HIV Research in South Africa - Krista Dong, iTeach, South Africa Sunnylands Retreat 2022: Ensuring Accessibility of Gene Therapy- Based Cures for HIV and Sickle Cell Disease - Sharon Lewin, IAS & The Peter Doherty Institute for Infection and Immunity, Australia
View details View details27 Jul 2022
Getting to the Heart of Stigma Pre-conference
This pre-conference is a thought-leadership symposium seeking to present, discuss and interrogate the state-of-the-field evidence base for HIV-related stigma. It will be a platform to discuss global financial, strategic and programmatic efforts to contextualize, implement and scale up effective stigma reduction and mitigation interventions. The latest results from a global systematic review will be presented, alongside nuanced national case studies and examples of good practice, to situate the evidence base considering day-to-day realities for different communities in specific socio-cultural and policy contexts. The symposium will also feature discussions based on current policy guidelines, original global and country-level research, and political documents to guide progress on stigma reduction and mitigation around the world. Expert speakers and participants will come from the whole spectrum of health (for example, psychology and mental health, general practice, nursing and midwifery, and sexual and reproductive health), as well as other sectors, such as education and justice. The programme will be of interest to a diverse audience, including participants from a background in policy, research, community activism, funding and grant making, politics and healthcare and people living with HIV. Coupled with the thorough context-specific review of existing evidence, this multidisciplinary and multisectoral engagement will not only amplify and accelerate attention to stigma, but is intended to broaden expert discussions about effective programming, measurement and concepts relating to stigma in ways that catalyse lateral thinking and lead to improved interventions. The pre-conference will take place on Wednesday, 27 July. The programme is as follows: Session 1: Leadership, 09:00 – 10:00 The opening session celebrates the courageous individuals and interventions that effectively challenge stigma and seek redress for discrimination. This session aims to inspire greater leadership to address stigma at scale. Session 2: State of the field evidence review, 10:15 – 11:15 The latest findings from a global systematic evidence review and progress towards consensus to guide scaled-up practical action will be presented. The comments will be framed within the context of progress, focusing on interventions and practical implications of research. Session 3: Uniting for a common vision and acknowledging local realities, 11:30 – 12:30 This session will debate how best to move forward by better documenting processes, evaluating progress, measuring change over time and maximizing learning across disciplines so that the specific context can also inform a broader view. Session 4: Role of partnerships in funding comprehensive responses to stigma and discrimination, 14:00 – 15:00 The session will explore the resourcing barriers and opportunities for joining up to reduce stigma at scale, including coordination between financing processes and organizations to be informed by evidence and fund strategies that work. Session 5: Addressing stigma is not enough, 15:15 – 16:15 Looking forward, we know that addressing stigma alone is not enough and addressing HIV-related stigma (in isolation) is not enough. Frameworks and visions that seek to strengthen efforts to address stigma must resonate within the broader programmatic approaches and commitments to achieving the societal enablers targets and improving or informing programmes and advocacy. The final session will explore how the inclusion of commitments toward eliminating HIV-related stigma and discrimination within the Political Declaration agreed at the 2021 United Nations High-Level Meeting on HIV/AIDS for the first time also signals a conducive global political environment for action at scale. Sessions will be interactive and include expert presentations with the opportunity to engage in discussion for those participating in person or virtually, as well as some smaller group discussions. We are grateful to the organizing committee, which has put together a strong and interesting programme: Lucy Stackpool-Moore, IAS – International AIDS Society, Switzerland and Watipa, Australia Sbongile Nkosi, Global Network of People Living with HIV (GNP+), South Africa Alexandrina Iovita, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland Leickness Simbayi, Human Sciences Research Council (HSRC), South Africa Carmen Logie, Factor-Inwentash Faculty of Social Work, University of Toronto; Women’s College Research Institute, Women’s College Hospital and Centre for Gender and Sexual Health Equity, Canada Laura Waters, British HIV Association (BHIVA), UK Ani Shakarishvili, Joint United Nations Programme on HIV/AIDS (UNAIDS), Switzerland James Hargreaves, London School of Hygiene and Tropical Medicine (LSHTM), UK Pascal Macharia, Health Options for Young Men on HIV/AIDS/STI (HOYMAS, )Kenya Erika Castellanos, Global Action for Trans Equality (GATE), The Netherlands We hope that you can join us in Montreal or virtually and sign up to join the IAS Community of Practice for getting to the heart of stigma.
View details View details
1 Jun 2022 - 2 Jun 2022
Reflections on the COVID-19 pandemic and its application to the HIV response in West and Central Africa
IAS – the International AIDS Society – and APIN Public Health Initiatives are pleased to invite you to a regional scientific symposium, “Reflections on the COVID-19 pandemic and its application to the HIV response in West and Central Africa”. Speakers and participants will discuss the following key and pressing topics for the region: HIV and COVID-19: West and Central African success stories Innovations in HIV testing and diagnostics: The path forward to scaling up HIV treatment and care for key populations in West and Central Africa Achieving and sustaining viral load suppression in paediatric care: Challenges and opportunities The symposium will benefit clinicians, HIV service providers, researchers, policy makers, activists and people living with and affected by HIV. French interpretation will be available for the entire symposium. View the full programme
View details View details
19 May 2022
Research priorities for an HIV cure: IAS Global Scientific Strategy
An HIV cure is a high priority for people living with HIV and an essential tool for the HIV response; a curative intervention could overcome the limitations of antiretroviral therapy (ART), limit new HIV transmissions, reduce stigma and discrimination, and provide a sustainable financial solution for epidemic control. IAS – the International AIDS Society – convened a 68-member International Scientific Working Group to develop the third Global Scientific Strategy, published in Nature Medicine in December 2021. Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021 is a comprehensive roadmap featuring the most pressing gaps in HIV cure research and research priorities to guide the field toward a widely accessible, acceptable and affordable cure. This webinar will take participants through the eight key focal areas of the strategy and how to apply the recommendations to their work.
View details View details